Pharmacists Play Role in Pharmacogenomics Clinical Services

In The News | May 13, 2022

Veronique Michaud, BPharm, PhD, Chief Operating Officer of TRHC Precision Pharmacotherapy Research and Development Institute; Jacques Turgeon, BPharm, PhD, TRHC Chief Scientific Officer and CEO of Precision Pharmacotherapy Research and Development Institute; and their co-authors address pharmacogenomics (PGx) in an article for Pharmacy Times. The article notes that PGx offers an opportunity for personalized medicine and discusses why pharmacists are well-suited to interpret PGx results.

Share this:

About the Author

Media Relations

Tabula Rasa HealthCare (TRHC) (NASDAQ: TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events – the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise® Science, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care.

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4